Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ February 4, 2023 ] senior Associate I, Technical Services – Kite Pharma – El Segundo, CA Los Angeles Biotech Jobs
  • [ February 4, 2023 ] Quality Assurance Specialist III – NKGen Biotech – Santa Ana, CA Los Angeles Biotech Jobs
  • [ February 4, 2023 ] Engineer I/II (Pharma Operations) – Glaukos Corporation – San Clemente, CA Los Angeles Biotech Jobs
  • [ February 4, 2023 ] First Look at Data on Biosense Webster’s Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023 Los Angeles Biotech News
  • [ February 4, 2023 ] Age-related macular degeneration (AMD) market size to increase by USD 4,360.68 million: Evolving Opportunities with Amgen Inc and Apellis Pharmaceuticals Inc among others – Technavio Los Angeles Biotech News
HomeLos Angeles Biotech NewsFor UCLA-based startup, new muscular dystrophy treatment is a personal mission

For UCLA-based startup, new muscular dystrophy treatment is a personal mission

February 24, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on For UCLA-based startup, new muscular dystrophy treatment is a personal mission

The post For UCLA-based startup, new muscular dystrophy treatment is a personal mission appeared first on Life Sciences.

Click to view original post

Previous

Veritone Announces Energy AI Integration with NVIDIA’s EGX AI Platform

Next

Opinion: Vaccine equity: If we build it, will they come?

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered